NCT06278324View on ClinicalTrials.gov

Effectiveness of a Nasal Spray on Viral Respiratory Infections

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

April 16, 2025

Study Completion Date

May 16, 2025

Conditions
Acute Respiratory Tract InfectionFlu, HumanCOVID-19Common Cold
Interventions
DEVICE

Nasal Spray HSV Treatment

Nasal treatment with the nasal spray Humer Stop Virus for 7 days, 2-3 puffs per nostril, 3-4 per day, space applications 4 hours apart.

Trial Locations (1)

21000

Cen Experimental, Dijon

Sponsors

Lead Sponsor

CEN Biotech
All Listed Sponsors
collaborator

Urgo Research, Innovation & Development

UNKNOWN

lead

CEN Biotech

INDUSTRY

NCT06278324 - Effectiveness of a Nasal Spray on Viral Respiratory Infections | Biotech Hunter | Biotech Hunter